据美国媒体报道,新发表的一项研究发现,一种罕见的基因突变可以防止人们患上II型糖尿病,可将患病风险降低了三分之二,如此显著的效果为制药公司开辟了一个新的前景:开发一种药物来模仿这种基因突变的效果。据报道,这项新研究是以15万人的基因测试结果为基础进行的。产生胰岛素的胰细胞使用的一个基因遭到这种突变的破坏。有这种基因变异的人产生的胰岛素比正常人略多,一生中的血糖水平都较普通人略低。 According to the U.S. media, a newly published study found that a rare genetic mutation prevents people from developing type 2 diabetes and reduces their risk by two-thirds. This remarkable effect opens up a gap for pharmaceutical companies New Prospects: Develop a drug to mimic the effect of this genetic mutation. It is reported that this new study is based on the genetic test results of 150,000 people. One gene used by insulin-producing pancreatic cells is destroyed by this mutation. People with this genetic variation produce slightly more insulin than normal people, with a slightly lower blood glucose level throughout their lives.